Sequential treatment with lymphoblastoid IFN alpha (IFN alpha-Ly) of Ph+ CML patients resistant to recombinant IFN alpha 2a (IFN alpha 2a): Evaluation of hematologic and karyotypic response in the neutralizing IFN alpha 2a antibodies (nIFN alpha 2a Abs) positive and negative patients

被引：0
|
作者：
Russo, D
Candoni, A
Zuffa, E
Minisini, R
Silvestri, F
Fanin, R
Lorenzon, A
Rosti, GA
Zaja, F
Tura, S
Baccarani, M
机构：
[1] UNIV UDINE,CHAIR MICROBIOL,I-33100 UDINE,ITALY
[2] UNIV BOLOGNA,INST HEMATOL L & A SERAGNOLI,BOLOGNA,ITALY
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [1] Response to sequential treatment with lymphoblastoid interferon-alpha in patients with Ph+ chronic myeloid leukemia unresponsive to recombinant interferon-alpha (rIFN alpha 2a) and neutralizing-rIFN alpha 2a antibodies negative
    Russo, D
    Candoni, A
    Grattoni, R
    Minisini, R
    Rosti, G
    [J]. HAEMATOLOGICA, 1997, 82 (03) : 348 - 350
  • [2] CHRONIC SYSTEMIC RECOMBINANT-ALPHA-2A-INTERFERON (R-ALPHA(2A)-IFN) INHIBITS LYMPHOCYTE GAMMA-IFN PRODUCTION IN MS
    BONGIOANNI, MR
    FERRIO, MF
    FERRERO, B
    VAI, S
    GEUNA, M
    DURELLI, L
    [J]. NEUROLOGY, 1993, 43 (04) : A164 - A164
  • [3] The influence of Escherichia coli cultivation temperature on interferon alpha 2a expression (IFN-α2a)
    Fernanda dos Santos Arthuso
    Miriam Fussae Suzuki
    Nélio Alessandro de Jesus Oliveira
    João Ezequiel de Oliveira
    Paolo Bartolini
    Carlos Roberto Jorge Soares
    [J]. BMC Proceedings, 8 (Suppl 4)
  • [4] Fate of antibody to interferon (IFN) in chronic hepatitis C patients treated with recombinant IFN alpha 2 and retreated with lymphoblastoid IFN alpha
    Antonelli, G
    Giannelli, G
    Currenti, M
    Simeoni, E
    Milella, M
    Schiraldi, O
    Dianzani, F
    [J]. INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1995, 4 (04): : 232 - 237
  • [5] Influence of therapy with ifn alpha 2a and consensus-IFN (IFN alpha-con) on the T-helper cell type 1 and type 2 reactivity in patients with hepatitis C
    Klein, R
    Kaiser, S
    Fischer, M
    Becker, WE
    Wiedenmann, B
    Hopf, U
    Gregor, M
    Berg, T
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 207 - 207
  • [6] DNA RECOMBINANT IFN ALPHA-2 (HU IFN ALPHA-2) IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    BRETAUDEAU, B
    PALANGIE, T
    JOUVE, M
    GARCIAGIRALT, E
    MATHIOT, C
    DERSTEPANI, L
    FALCOFF, E
    SCHWAB, D
    POUILLART, P
    [J]. BULLETIN DU CANCER, 1984, 71 (01) : 75 - 76
  • [7] Treatment of interferon-alpha 2A(IFN)-induced thrombocytopenia by the pineal neurohormone melatonin (MTL)
    Lissoni, P
    Barni, S
    Tancini, G
    Adizzoia, A
    Paolorossi, F
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 583 - 583
  • [8] African-american patients with chronic hepatitis c respond similarly to PEG-IFN alpha 2a and ribavirin as compared to PEG-IFN alpha 2b and ribavirin
    Khan, Afreen
    Mutchnick, Milton
    Ehrinpreis, Murray
    Siddiqui, Firdous
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S124 - S124
  • [9] Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph(+) chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha
    Russo, D
    Candoni, A
    Zuffa, E
    Minisini, R
    Silvestri, F
    Fanin, R
    Zaja, F
    Martinelli, G
    Tura, S
    Botta, G
    Baccarani, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (02) : 300 - 305
  • [10] RECOMBINANT HUMAN IFN ALPHA-2 (RHU-IFN-ALPHA-2) IN ADVANCED BREAST-CANCER
    LENZHOFER, R
    MICKSCHE, M
    DITTRICH, C
    GRANINGER, W
    JAKESZ, R
    KOLB, R
    MOSER, K
    [J]. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1984, 10 (07) : 463 - 470
12345